Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant - PA: Breast Cancer Research

University of Ottawa

$100,000.00

Investigating the role of a lysine methyltransferase in breast cancer progression

FY 2022-23

Summary
If someone in your family has been diagnosed with metastatic breast cancer, they are not alone. Metastatic breast cancer is gradually becoming the most common cancer among Canadian women (average 14 Canadian women will die from it each day in 2020). Metastatic breast cancer is also called stage IV or the most advanced stage of breast cancer, and for some unknown reasons, it reappears years after completion of the initial treatment of localized cancer. Even though there lies no cure for metastatic breast cancer, treatments are available to enhance life expectancy and improve quality of life. At some point, however, during treatment, few cancer cells develop an alternate strategy against the treatment, resulting in cancer recurrence. Therefore, it is essential to better understand the biological events that lead to cancer metastasis and design novel therapeutics. A large amount of evidence indicates that dysregulated expression of protein lysine methyltransferases (PKMTs), a unique class of enzymes that catalyze the methylation of target proteins, has been implicated in breast cancer, hence represents a novel class of targets for next-generation cancer therapy. The goal of our proposal is to study the expression of one such methyltransferase protein, SMYD5, in diseased and normal breast tissues. Normally, methyltransferase proteins interact and regulate other proteins, eventually activating a cascade of events. This research program aims to identify the interacting proteins of SMYD5 and understand the correlation between protein methylation and breast cancer metastasis. More than just delineating the novel signalling pathways of breast cancer metastasis, this project could unravel new promising therapeutic options with improved outcomes of this aggressive disease.
Program
Project Grant - PA: Breast Cancer Research
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
472377
Name
Couture Jean-François
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Molecular & Cellular Biology of Cancer
Projecttitle
Investigating the role of a lysine methyltransferase in breast cancer progression
Programtype2
Operating Grants
Orgnameinp2
University of Ottawa
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant - PA: Breast Cancer Research
Keyworddelim
Breast Cancer; Cytoskeleton; Metastasis; Methyltransferase; Migration; Tumor Growth
Abstract
If someone in your family has been diagnosed with metastatic breast cancer, they are not alone. Metastatic breast cancer is gradually becoming the most common cancer among Canadian women (average 14 Canadian women will die from it each day in 2020). Metastatic breast cancer is also called stage IV or the most advanced stage of breast cancer, and for some unknown reasons, it reappears years after completion of the initial treatment of localized cancer. Even though there lies no cure for metastatic breast cancer, treatments are available to enhance life expectancy and improve quality of life. At some point, however, during treatment, few cancer cells develop an alternate strategy against the treatment, resulting in cancer recurrence. Therefore, it is essential to better understand the biological events that lead to cancer metastasis and design novel therapeutics. A large amount of evidence indicates that dysregulated expression of protein lysine methyltransferases (PKMTs), a unique class of enzymes that catalyze the methylation of target proteins, has been implicated in breast cancer, hence represents a novel class of targets for next-generation cancer therapy. The goal of our proposal is to study the expression of one such methyltransferase protein, SMYD5, in diseased and normal breast tissues. Normally, methyltransferase proteins interact and regulate other proteins, eventually activating a cascade of events. This research program aims to identify the interacting proteins of SMYD5 and understand the correlation between protein methylation and breast cancer metastasis. More than just delineating the novel signalling pathways of breast cancer metastasis, this project could unravel new promising therapeutic options with improved outcomes of this aggressive disease.
Competitiondate
202209
Approvedterm2
1 yr 0 mth
Pinamesdelim
Couture, Jean-François
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~
University of Ottawa - $100,000 Grant (2022-23) | Canada Spends